Journal: Reviews on Recent Clinical Trials Volume: 16 Issue: 3 Year: 2021 Page: 294-302 Author(s): Mourad Akdad,Youness Algharrass,Hafid Talha,Abdelaadim Babakhouya,Mohammed Ajebli,Ahlam Ech-cherrate,Mohamed Eddouks
Journal: Cardiovascular & Hematological Disorders-Drug Targets Volume: 18 Issue: 1 Year: 2018 Page: 71-80 Author(s): Morad Hebi,Mohamed Eddouks
Journal: Cardiovascular & Hematological Disorders-Drug Targets Volume: 17 Issue: 2 Year: 2017 Page: 142-152 Author(s): Mohammed Ajebli,Mohamed Eddouks
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets Volume: 21 Issue: 4 Year: 2021 Page: 711-719 Author(s): Fadwa El-Ouady,Mohamed Eddouks
Journal: Cardiovascular & Hematological Disorders-Drug Targets Volume: 20 Issue: 4 Year: 2020 Page: 297-304 Author(s): Ayoub Amssayef,Mohammed Ajebli,Mohamed Eddouks
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry Volume: 20 Issue: 3 Year: 2022 Page: 197-211 Author(s):
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets Volume: 21 Issue: 3 Year: 2021 Page: 434-440 Author(s): Ayoub Amssayef,Nadia Lahrach,Mohamed Eddouks
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets Volume: 20 Issue: 5 Year: 2020 Page: 736-744 Author(s): Fadwa El-Ouady,Mohamed Eddouks
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets Volume: 19 Issue: 4 Year: 2019 Page: 503-510 Author(s): Mohamed Eddouks,Farid Khallouki,Robert W. Owen,Morad Hebi,Remy Burcelin
Journal: Cardiovascular & Hematological Disorders-Drug Targets Volume: 18 Issue: 3 Year: 2018 Page: 239-246 Author(s): Mohammed Ajebli,Mohamed Eddouks
Previous Next